The Story of RU-486 in the United States
dc.contributor.advisor | Hutt, Peter Barton | en_US |
dc.contributor.author | Pinho, Elizabeth | en_US |
dc.date.accessioned | 2012-06-15T20:29:51Z | |
dc.date.issued | 2001 | en_US |
dc.identifier.citation | The Story of RU-486 in the United States (2001 Third Year Paper) | en |
dc.identifier.uri | http://nrs.harvard.edu/urn-3:HUL.InstRepos:8889480 | |
dc.description.abstract | In this paper, I will navigate you through the fascinating odyssey of RU-486 from its initial development in France to its official entry into the U.S. pharmaceutical market to the post-approval strife in which it is now embroiled. While many assumed that the FDA’s approval of RU-486 on September 28, 2000 would mark the final chapter in the story of the drug’s acceptance as an early pregnancy termination procedure, it actually marked the beginning of a new chapter, which ignited congressional efforts to stymie, or even abort, the growth of this chemical alternative to surgical abortion in the United States. As a result of these congressional efforts, the last chapter in the story of RU-486 remains to be written. | en |
dc.language.iso | en_US | en |
dash.license | LAA | en_US |
dc.subject | Food and Drug Law | en |
dc.subject | RU-486 | en |
dc.subject | abortion pill | en |
dc.subject | FDA | en |
dc.title | The Story of RU-486 in the United States | en |
dc.type | Paper (for course/seminar/workshop) | en_US |
dc.date.available | 2012-06-15T20:29:51Z | |
dash.authorsordered | false |
Files in this item
This item appears in the following Collection(s)
-
HLS Student Papers [498]